Figure 1.

Glucose profiles (a), daily hypoglycemic episodes (b–d), and daily insulin doses (e, f) of patients during continuous subcutaneous insulin infusion (CSII) therapy in the remission group and the nonremission group. Compared with those in the nonremission group, patients in the remission group had a lower mean glucose, an increased mild hypoglycemia episode, a higher initial insulin dose, and a lower dose before removal of the insulin pump. Glucose profiles (a) and daily insulin doses (e, f) were compared by t-test. The number of hypoglycemic episodes (b–d) was calculated by rank-sum tests. ∗ means P < 0.05.